<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta name="viewport" content="width=device-width, initial-scale=1">



<title>test_posterdown.utf8</title>






<!--
Font-awesome icons ie github or twitter
-->
<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/all.css" integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf" crossorigin="anonymous">
<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/brands.css" integrity="sha384-n9+6/aSqa9lBidZMRCQHTHKJscPq6NW4pCQBiMmHdUCvPN8ZOg2zJJTkC7WIezWv" crossorigin="anonymous">

<!--
Google fonts api stuff
-->
<link href='https://fonts.googleapis.com/css?family=Palatino' rel='stylesheet'>
<link href='https://fonts.googleapis.com/css?family=Rasa' rel='stylesheet'>

<!--
Here are the required style attributes for css to make this poster work :)
-->
<style>
@page {
size: 11.69in 16.53in;
margin: 0;
padding: 0;
}
body {
margin: 0px;
padding: 0px;
width: 11.69in;
height: 16.53in;
text-align: justify;
font-size: 14px;
line-height: 1.05;
}
/* RMarkdown Class Styles */
/* center align leaflet map,
from https://stackoverflow.com/questions/52112119/center-leaflet-in-a-rmarkdown-document */
.html-widget {
margin: auto;
position: sticky;
margin-top: 2cm;
margin-bottom: 2cm;
}
.leaflet.html-widget.html-widget-static-bound.leaflet-container.leaflet-touch.leaflet-fade-anim.leaflet-grab.leaflet-touch-drag.leaflet-touch-zoom {
position: sticky;
width: 100%;
}
pre.sourceCode.r {
background-color: #dddddd40;
border-radius: 4mm;
padding: 4mm;
width: 75%;
margin: auto;
margin-top: 1em;
margin-bottom: 1em;
/* align-items: center; */
}
code.sourceCode.r{
background-color: transparent;
font-size: 20pt;
border-radius: 2mm;
}
code {
font-size: 25pt;
font-family: monospace;
background-color: #00808024;
color: #0b4545;
padding: 1.2mm;
line-height: 1;
border-radius: 2mm;
}
caption {
margin-bottom: 10px;
font-size: 14px;
font-style: italic;
}

tbody tr:nth-child(odd) {
    background-color: #00808020;
}
.table>thead>tr>th, .table>tbody>tr>th, .table>tfoot>tr>th, .table>thead>tr>td, .table>tbody>tr>td, .table>tfoot>tr>td{
  border-spacing: 0;
  font-size: 40%;
  border-style: none;
  padding-top: 15px;
  padding-bottom: 15px;
  padding-right: 1em;
  padding-left: 1em;
  line-height: 1em;
}
table {
  margin: auto;
}
th {
  padding-left: 5mm;
  padding-right: 5mm;
}
.caption {
font-size: 14px;
font-style: italic;
padding-top: 0;
}
.references {
font-size: 14px;
line-height: 90%;
}
/* Create three unequal columns that floats next to each other */
.column {
float: left;
padding: 0px;
}
.outer {
width: 11.69in;
height: calc(16.53in *  (1 - 0.1 - 0.04 - 0.01) );
-webkit-column-count: 2; /* Chrome, Safari, Opera */
-moz-column-count: 2; /* Firefox */
column-count: 2;
-webkit-column-fill: auto;
-moz-column-fill: auto;
column-fill: auto;
column-gap: 0;
padding-left: 0cm;
padding-right: 0cm;
/* -webkit-column-rule-width: 50%;
-moz-column-rule-width: 50%;
column-rule-width: 50%; */
-webkit-column-rule-style: none;
-moz-column-rule-style: none;
column-rule-style: none;
-webkit-column-rule-color: black;
-moz-column-rule-color: black;
column-rule-color: black;
background-color: #ffffff;
font-family: Rasa;
margin-top: calc(16.53in *  0.1 );
padding-top: 1em;
padding-bottom: 1em;
}
span.citation {
  color: #008080;
  font-weight: bold;
}
a {
text-decoration: none;
color: #008080;
}
#title {
font-size: 125pt;
text-align: left;
margin: 0;
line-height: 98%;
border-bottom: 0;
font-weight: normal;
background: 0;
}
#author {
color: #0b4545;
margin: 0;
line-height: 85%;
font-size: 20px;
}
#affiliation {
padding-top: 0.1em;
color: ;
font-style: italic;
font-size: 14px;
margin: 0;
}
sup {
color: #cc0000;
}
.affiliation sup {
font-size: 20px;
}
.author {
text-align: left;
}
.author sup {
font-size: 30px;
}
.author_extra {
color: #008080;
margin: 0;
line-height: 85%;
font-size: 14px;
text-align: left;
}
.outer h1, h2, h3, h4, h5, h6 {
text-align: center;
margin: 0;
font-weight: bold;
}
.section h1 {
  text-align:center;
  padding-bottom:5px;
  background:
    linear-gradient(
      to left,
      #ffffff 1%,
      #ffffff 20%,
      #0b454575 33%,
      #0b4545 50%,
      #0b454575 66%,
      #ffffff 80%,
      #ffffff 99%
    )
    left
    bottom
    #ffffff
    no-repeat;
  background-size:100% 5px ;
  margin-top: 0.5em;
  margin-bottom: 0.5em;
}
.outer h2 {
text-align: center;
}
.outer p, .level2 {
color: #000000;
}
.outer ol {
padding-left: 8%;
padding-right: 8%;
text-align: left;
}
.main {
width: 11.69in;
height: calc(16.53in * 0.1);
position: absolute;
background-color: #0b4545;
color: #ffffff90;
font-family: Palatino;
background-image: linear-gradient(#0b4545 50%,#008080);
}
.main strong {
color: #ffffff;
}
.main strong > sup {
color: #ffffff;
}
.main sup {
color: #ffffff90;
}
#main-img-left {
width: 10%;
left: 0.5in;
bottom: 0.2in;
position: absolute;
}
#main-img-center {
width: 10%;
left: calc(11.69in * 0.45);
bottom: 0.5in;
position: absolute;
}
#main-img-right {
width: 10%;
right: 0.5in;
bottom: 0.2in;
position: absolute;
}
.main p {
font-size: 42px;
font-family: Palatino;
text-align: center;
margin: 0;
position: absolute;
top: 50%;
-ms-transform: translateY(-50%);
transform: translateY(-50%);
margin-left: 1em;
}
.fab {
color: #00000030;
font-size: 25px;
}
.twitter, i {
color: #00000030;
font-size: 35px;
text-decoration: none;
}
a.email {
text-decoration: none;
color: #00000030;
font-size: 35px;
}
.envelope {
color: #00000030;
font-size: 5px;
text-decoration: none;
}
.poster_wrap {
width: 11.69in;
height: 16.53in;
padding: 0cm;
}
.main_bottom {
width: 11.69in;
height: calc(16.53in * 0.04);
margin-top: calc(16.53in * (1 - 0.04));
position: absolute;
background-color: #0b4545;
background-image: linear-gradient(#008080 10%, #0b4545);
}
.section {
  padding-left: 10mm;
  padding-right: 10mm;
}
span > #tab:mytable {
  font-weight: bold;
}
.orcid img {
  width: 3%;
}
.emphasis {
  background-color: #008080;
  color: #ffffff;
  border: solid #0b2045 3mm;
  margin: 1em;
  padding-left: 0;
  padding-right: 0;
}
.emphasis h1 {
  font-weight: bold;
  background: none;
  background-color: #0b2045;
  padding-bottom: 5mm;
  padding-top: 1mm;
  margin-top: -1mm;
  margin-right: -1mm;
  margin-left: -1mm;
}
.emphasis blockquote {
  border: 0;
}
.emphasis ol {
  padding: 0;
  padding-left: 8%;
  font-size: 100%;
  font-weight: bold;
}
.emphasis p {
  color: #ffffff;
}
</style>
</head>
<body>


<div class="poster_wrap">

<div class="column outer">
<div class="section">

<h3 id="author" class="author">

<strong>First Author (670000131)</strong><sup> 1</sup><br>

  </h3>

<h5 id="author_extra", class="author_extra">
 Dr. Abu Bhakar<sup>2</sup>
 Prof. Julie Thacker<sup>1</sup>
</h5>


<p id="affiliation" class="affiliation">
<sup>1</sup> University of Exeter Medical School, Exeter, United Kingdom<br> <sup>2</sup> Lalibela Hospital, Amhara, Ethiopia
</p>
</div>

<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>Human immunodeficiency virus (HIV) prevalence in Ethiopia is 1.0
(95% credibility interval 0.7-1.4) per 100,000 population; ten-fold higher
than the UK <span class="citation">(<a href="#ref-unaids_unaids_2019">1</a>)</span>.<br />
In Amhara region, north-eastern Ethiopia,
1.2% (95%CI 0.7-1.4) of people had HIV in 2016 <span class="citation">(<a href="#ref-kibret_trends_2019">2</a>)</span>.<br />
While antiretroviral therapy (ART) has improved outcomes in most countries;
economically deprived rural areas still struggle with treatment retention and
viral suppression. Thus immunocompromised patients suffer from infections they
otherwise would not; contributing to a higher rate of mortality.<br />
Lalibela hospital in Amhara has some diagnostic laboratory capacity and an
outpatient HIV department delivering ART. It is unclear whether there are
facilities for opportunistic infections in advanced HIV
infection (CD4 cell count &lt;200/ml) <span class="citation">(<a href="#ref-assefa_outcomes_2011">3</a>)</span>.<br />
This project aims to understand local hospital capacity in addressing diagnosis
and management of opportunistic infections among HIV infected people,
as well as patient outcomes.</p>
<div id="objectives" class="section level2">
<h2>Objectives</h2>
<ol style="list-style-type: decimal">
<li>Describe HIV patient care pathway in the Lalibela healthcare system.</li>
<li>Describe diagnostic and management facilities in Lalibela hospital.</li>
<li>Describe outcomes among patients in care.</li>
</ol>
</div>
</div>
<div id="methods" class="section level1">
<h1>Methods</h1>
<p>This project involved a mixed methods approach, incorporating qualitative and
quantitave aspects.<br />
The qualitative approach involved guideline review and semi-structured interviews
with local health care providers.<br />
The qualitative approach involved gathering health system indicators in the form
of aggregate counts. This indicator data was gathered during the semi-structured
interviews and included:</p>
<ul>
<li><em>Total catchment population</em><br />
</li>
<li><em>Number HIV cases in hospital cohort</em><br />
</li>
<li><em>Number cases with advanced HIV (CD4 cell count &lt; 300 cells/mm<sup>3</sup>)</em></li>
<li><em>Number of patients with laboratory tests for opportunistic infections</em></li>
<li><em>Number of patients testing positive for opportunistic infections</em></li>
<li><em>Number of patients virally suprssed</em></li>
</ul>
</div>
<div id="results" class="section level1">
<h1>Results</h1>
<p><strong>Patient care pathway</strong></p>
<p>A decentralised healthcare system serving an ~350,000 catchment population; with 5 community health
centres reporting to Lalibela hospital and 25 health posts reporting to each health centre, Figure <a href="#fig:healthsystem">1</a>.</p>
<ul>
<li>All hospital departments offer HIV RDT (high suspects tested)</li>
<li>Health posts also have HIV RDT testing</li>
<li>Initial and annual follow-up at hospital
<ul>
<li>CD4, Viral load, malnutrition screening</li>
</ul></li>
<li>Medication dispensed at health centres
<ul>
<li>Ease of access leading to better conitnuity of care</li>
</ul></li>
<li>All health care free under national insurance</li>
<li>National HIV programme supported by the Global Fund for HIV, TB and Malaria</li>
</ul>
<div class="figure" style="text-align: center"><span id="fig:healthsystem"></span>
<img src="test_posterdown_files/figure-html/healthsystem-1.png" alt="Visualisation of the health system in the Lalibela hospital catchment area" width="80%" />
<p class="caption">
Figure 1: Visualisation of the health system in the Lalibela hospital catchment area
</p>
</div>
<p><br>
<br></p>
<p><strong>Diagnostics &amp; management</strong></p>
<p>There is a clear patient management pathway defined by a national programme.<br />
The hospital has well resourced laboratory capacity, which is supported by
the US Centre for Disease Control and Prevention as well as Tulane
University. The available lab test and management at the hospital level are displayed
in Table <a href="#tab:labtable">1</a>.</p>
<ul>
<li>Viral load and HIV resistance testing sent to capital lab (25 days for results)<br />
</li>
<li>CD4 count tests available at hospital</li>
<li>All patients presenting with CD4 count &lt;350 prophylactically given broad spectrum ABx against diarrhoea and fungal infections</li>
</ul>
<table>
<caption>
<span id="tab:labtable">Table 1: </span>Diagnostic and management facilities for HIV associated OIs
</caption>
<thead>
<tr>
<th style="text-align:center;">
Disease
</th>
<th style="text-align:center;">
Diagnostics
</th>
<th style="text-align:center;">
Management
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:center;">
Tuberculosis
</td>
<td style="text-align:center;">
Microscopy <br> PCR
</td>
<td style="text-align:center;">
Negative: prophylatic Isoniazide <br> Positive: Tripple therapy
</td>
</tr>
<tr>
<td style="text-align:center;">
Sexually Transmitted Infections
</td>
<td style="text-align:center;">
ELISA
</td>
<td style="text-align:center;">
Broad spectrum ABx
</td>
</tr>
<tr>
<td style="text-align:center;">
Crytococcal Meningitis
</td>
<td style="text-align:center;">
Culture
</td>
<td style="text-align:center;">
Appropriate ABx
</td>
</tr>
<tr>
<td style="text-align:center;">
Viral Hepatitis (B &amp; C)
</td>
<td style="text-align:center;">
PCR <br>
ELISA
</td>
<td style="text-align:center;">
Patient pays privately for test, <br>
managment privately in capital
</td>
</tr>
</tbody>
</table>
<p><strong>Outcomes</strong></p>
<p>With the national pharmacy association supplying hospitals, there are infrequent
ruptures. However there are shortages of second line ARV. Despite this there are
quite impresive outcomes as seen in Figure <a href="#fig:cascade">2</a>.</p>
<ul>
<li>88% of those in the cohort are virally surpressed</li>
<li>Among those with OIs: 55 had diarrhoea or skin infections, only 1 patient with extrapulmonary TB</li>
</ul>
<div class="figure" style="text-align: center"><span id="fig:cascade"></span>
<img src="test_posterdown_files/figure-html/cascade-1.png" alt="Cascade of care for opportunistic infections among HIV infected patients &lt;br&gt; (N = 350,000)" width="80%" />
<p class="caption">
Figure 2: Cascade of care for opportunistic infections among HIV infected patients <br> (N = 350,000)
</p>
</div>
</div>
<div id="discussion-conclusion" class="section level1">
<h1>Discussion / Conclusion</h1>
<p>The estimated HIV prevalence based on the hospital catchment population is much lower
than literature described values for the region.<br />
This along with the annecdotal reasoning that Lalibela prefecture is better off
than the surrounding region may explain the very impressive outcomes.<br />
Nevertheless this appears to be a well structured and resourced health system
for addressing opportunistic infections in HIV patients.
Future studies should consider the impact on TB monotherapy on antimicrobial resistance
prevalence, as well as the potential impact of making viral hepatitis testing and
management locally available free of charge.</p>
</div>
<div id="references" class="section level1 unnumbered">
<h1>References</h1>
<div id="refs" class="references">
<div id="ref-unaids_unaids_2019">
<p>1. UNAIDS. UNAIDS data 2019. Joint United Nations Programme on HIV/AIDS (UNAIDS); 2019. </p>
</div>
<div id="ref-kibret_trends_2019">
<p>2. Kibret GD, Ferede A, Leshargie CT, Wagnew F, Ketema DB, Alebel A. Trends and spatial distributions of HIV prevalence in Ethiopia. Infectious Diseases of Poverty. 2019 Oct;8(1):90. </p>
</div>
<div id="ref-assefa_outcomes_2011">
<p>3. Assefa Y, Kiflie A, Tesfaye D, Mariam DH, Kloos H, Edwin W, et al. Outcomes of antiretroviral treatment program in Ethiopia: Retention of patients in care is a major challenge and varies across health facilities. BMC Health Services Research. 2011 Apr;11(1):81. </p>
</div>
</div>
</div>

</div>
<div class="main">
<p>Opportunistic infections in HIV: <br> diagnostics, management &amp; outcomes in rural Ethiopia</p>
</div>
<div class="main_bottom">
<img id="main-img-left" src=https://www.exeter.ac.uk/departments/communication/communications/design/downloads/logos/white_logo.png>
<img id="main-img-center" src=>
<img id="main-img-right" src=>
</div>
</div>



</body>
</html>
